TY - JOUR AU - Anna Franceschino, AU - Lucia Tornaghi, AU - Valerie Benemacher, AU - Sarit Assouline, AU - Carlo Gambacorti-Passerini, PY - 2008/01/31 Y2 - 2024/03/28 TI - Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib JF - Haematologica JA - haematol VL - 93 IS - 2 SE - Letters to the Editor DO - 10.3324/haematol.11680 UR - https://haematologica.org/article/view/4762 SP - 317-318 AB - Imatinib, the treatment of choice for chronic myeloid leukemia, is generally well tolerated. We present here data from a retrospective analysis on metabolic abnormalities occurring during therapy which show increased creatine kinase, inverse creatine kinase-phosphate correlation, cholesterol and triglyceride values. ER -